The Schistosomiasis Control Initiative (SCI) is a collaborative project to assist countries in sub Saharan Africa control schistosomiasis, intestinal helminths and other Neglected Tropical Diseases (NTDs). The SCI was created in 2002 and has since expanded to become one of the major implementing partners for the controlf of schistosomiasis.
Arminder Deol joined SCI as an operational researcher in September 2013 on a Children's Investment Fund Foundation (CIFF) funded project, with a focus on developing tools and providing evidence to help reach the WHO aims of the control and elimination of STH infection and schistosomiasis. She is currently working together with the WHO and modelling groups as well as the Ministries of Health of endemic countries to develop tools and strategies for control programmes and provide evidence through a three year data collection exercise in Uganda involving 7,500 individuals across all age groups, as well as through analysis of SCI's extensive historical datasets. The evidence gathered will help assist the WHO in the refinement of the guidelines on the way forward to reach the ambitious WHO 2020 targets of controlling and eliminating these debilitating diseases .
Prior to working for SCI on the CIFF grant, Arminder had worked in population genetics of schistosomiasis at the Dept. of Infectious Disease Epidemiology with Professor Joanne Webster (as well as completing her MSc in Modern Epidemiology with a specialisation in infectious diseases and a final dissertation in mathematical modelling of ascaris infection with Dr James Truscott). She has worked with the Partnership for Child Development providing statistical support, as well as SCI with operational research data. She was also involved with the data collection from Mozambique, where she spent several weeks in the field with Dr Anna Phillips and local staff, assisting the teams and identifying infection intensities through microscopy as part of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) project. Arminder has also worked for a private organisaton where she was involved in the development of an economic Markov STI model (gonorrhoea, chlamydia and coinfection) and has spent several weeks in China where she collected and analysed samples from the field for Paragonimus westermani using various laboratory techniques, with Dr Charlotte Gower at the Dept. of Infectious Disease Epidemiology.
et al., 2017, Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations, Parasites & Vectors, Vol:10, ISSN:1756-3305
et al., 2016, Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali, Parasites & Vectors, Vol:9, ISSN:1756-3305
et al., 2016, Markov Model Predicts Changes in STH Prevalence during Control Activities Even with a Reduced Amount of Baseline Information, PLOS Neglected Tropical Diseases, Vol:10, ISSN:1935-2735
et al., 2014, An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England, Sexually Transmitted Infections, Vol:90, ISSN:1368-4973, Pages:104-111
et al., 2013, Population genetic structure of Schistosoma mansoni and Schistosoma haematobium from across six sub-Saharan African countries: Implications for epidemiology, evolution and control, Acta Tropica, Vol:128, ISSN:0001-706X, Pages:261-274